A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

Clinical trial NCT01603069 · COMPLETED

Trial details

NCT number: NCT01603069
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2012-10-01
Primary completion: 2013-06-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.